EU ARCHIVE
- UPDATE – Visionary Doubles Down on High-Margin Medical Aesthetics with US$12 Million Exclusive Agreement, Initiates Strategic Exit from Non-Core Businesses
Visionary Holdings Inc. to divest non-core businesses, enters $12M anti-aging deal
- YY Group Announces Preliminary Fiscal Year 2025 Financial Highlights
YY Group to report estimated FY2025 revenue $57-58 million, up 38.7-41.1% YOY, and estimated gross profit $7.5-8 million, up 42.6-52.1% YOY.
- Eagle Nuclear Energy Corp. to Ring Nasdaq Opening Bell on March 11
Eagle Nuclear Energy Corp. to make Nasdaq debut
- QCi completes acquisition of quantum communications firm NuCrypt
QCi completes acquisition of NuCrypt to advance quantum communications technology and expand portfolio.
- Lyell Immunopharma Announces Closing of Additional $50 Million Tranche of Equity Private Placement and Appointment of Smital Shah as Chief Financial and Business Officer
Lyell Immunopharma closes $50M equity private placement, appoints Smital Shah as CFO.
- electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2025, Financial Results on Thursday, March 19, 2026
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2025, Financial Results on Thursday, March 19, 2026
- Schouw & Co. share buy-back programme, week 10 2026
Schouw & Co. initiates share buy-back programme for up to DKK 240 million.
- Nasus Pharma to Present and Participate in the Upcoming Life Sciences Investor Forum
Nasus Pharma to present and participate in the upcoming Life Sciences Investor Forum.
- Mirai Robotics raises $4.2M pre-seed to build autonomous and intelligent maritime systems to master every sea
Mirai Robotics raises $4.2M to build autonomous maritime systems
- Women and the Mideast’s Energy Future
Women's participation is essential for building resilient energy systems in the Middle East.
- Data Published in Neurology and Therapy Demonstrate Significant Reductions in Relapse and MRI Activity with BRIUMVI® in People with Highly Active Relapsing Multiple Sclerosis
BRIUMVI reduces relapse rates and MRI activity in highly active multiple sclerosis
- SL Green Reaches 100% Leased at the Transformative One Madison Avenue, Projects Record-Breaking First Quarter Office Leasing Across Portfolio
SL Green reaches 100% leased at One Madison Avenue, projects record-breaking first quarter office leasing across portfolio.
- Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJectTM Dataset
73% clinical clearance in 200-μg cohort at Day 57.
- FuelCell Energy Delivers Strong Q1’26 Revenue Growth vs Q1’25; Advances Data Center Power Strategy
FuelCell Energy reports strong revenue growth in Q1'26, expands data center power strategy, announces significant orders for its power-to-gas solutions.
- Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update
Corbus Pharmaceuticals Holdings, Inc. reports Q4 and 2025 financial results
- FTI Consulting Elects Angela Nam as Chief Financial Officer
FTI Consulting elects Angela Nam as Chief Financial Officer.
- Skyharbour JV Partner Denison Mines Commences Winter Drill Program at the Wheeler North Joint Venture in Northern Saskatchewan
Skyharbour Resources commences winter drilling program at Wheeler North Joint Venture in Saskatchewan.
- NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study
NovaBridge and Visara announce positive results from Phase 2a VIS-101 study for wet AMD.
- Cartesian Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update
Enrollment in Phase 3 AURORA trial of Descartes-08 in myasthenia gravis continues to progress.
- Osisko Development Announces Proceeds of $24.9 Million From Warrant Exercise
Osisko Development Corp. exercises warrants for $24.9 million.
- pH Sensors Market Size to Hit USD 1.90 Billion by 2035 | Research by SNS Insider
Global pH sensor market is expected to reach USD 1.90 billion by 2035.
- Relmada Therapeutics Reports 12-Month Phase 2 Interim Data for NDV-01 in Non-Muscle Invasive Bladder Cancer
Relmada Therapeutics reports interim data from Phase 2 trial for NDV-01 in non-muscle invasive bladder cancer.
- Coin used to pay bus fare in Leeds was made by ancient civilisation more than 2,000 years ago
A 2,000-year-old coin was discovered in a Leeds bus depot.
- G Mining Ventures Receives Notice of Exercise of Top-up Right from La Mancha
La Mancha S.a.r.L. exercises top-up right to increase ownership up to 19.9%.
- Silver Miners (SIL): Identifying the next support zone
Key support level identified at $24.50, SIL has been trading below this level since October, making it a potential buying opportunity, SIL's 200-day moving average has also formed a support level at $25.60.
- UK PM Starmer: Longer this conflict more likely the potential economic impact
UK PM warns of potential economic impact of ongoing war
- ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on neffy® (epinephrine nasal spray) Commercialization
ARS Pharmaceuticals reports its first full year of neffy revenues of $72.2 million.
- Aspocomp returns to profit in 2025
Aspocomp Group reports strong revenue growth of 38% in 2025, driven by demand from the semiconductor and defence sectors.
- Mullen Group Ltd. Announces Renewal of Normal Course Issuer Bid
Mullen Group Ltd. has received approval to renew its normal course issuer bid.
- Auddia Showcases Discovr Radio at 2026 SXSW with Live Demo Listening Events and Brand Activation within the Artist Lounge
Auddia to showcase Discovr Radio at SXSW 2026
- Ridgeline Surpasses $650B in Committed AUM as Investment Managers Embrace the AI-Native Platform
Ridgeline surpasses $650B in AUM